Aliases & Classifications for Adenoma

Aliases & Descriptions for Adenoma:

Name: Adenoma 12 52 14 69
Acinar Cell Adenoma 12 69
Adenomas 12 14
Acinic Cell Adenoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:657
MeSH 42 D000236
NCIt 47 C2855 C4196

Summaries for Adenoma

Disease Ontology : 12 A cell type benign neoplasm that is composed_of epithelial tissue in which tumor cells form glands or glandlike structures.

MalaCards based summary : Adenoma, also known as acinar cell adenoma, is related to pituitary adenoma, acth-secreting and water-clear cell adenoma. An important gene associated with Adenoma is PLAG1 (PLAG1 Zinc Finger), and among its related pathways/superpathways are PI3K-Akt signaling pathway and Development ERBB-family signaling. The drugs Dopamine and Aspirin have been mentioned in the context of this disorder. Affiliated tissues include pituitary, thyroid and colon, and related phenotypes are Increased shRNA abundance (Z-score > 2) and cellular

Wikipedia : 71 An adenoma (from Greek αδένας, adeno-, \"gland\" + -ώμα, -oma, \"tumor\") (/ˌædᵻˈnoʊmə/;... more...

Related Diseases for Adenoma

Diseases related to Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 733)
id Related Disease Score Top Affiliating Genes
1 pituitary adenoma, acth-secreting 33.7 GNAS PRL SST
2 water-clear cell adenoma 33.5 POMC SST
3 prostatic adenoma 33.2 CTNNB1 KRAS MLH1 TP53
4 vaginal adenoma 32.9 POMC SST
5 wolffian duct adenoma 32.8 GNAS KRAS MLH1
6 hidradenoma 31.9 CCND1 KRAS MLH1 MUTYH TP53
7 glycogen storage disease 30.1 CTNNB1 KRAS MLH1 TGFBR2 TP53
8 large cell neuroendocrine carcinoma 29.7 GNAS KRAS SST
9 pituitary adenoma 12.2
10 adrenal adenoma 12.1
11 parathyroid adenoma 12.1
12 pituitary adenoma, growth hormone-secreting 12.1
13 pituitary adenoma, prolactin-secreting 12.1
14 hepatocellular adenoma 12.1
15 villous adenoma 12.1
16 colorectal adenoma 12.1
17 pleomorphic adenoma 12.1
18 familial isolated pituitary adenoma 12.0
19 sebaceous adenoma 12.0
20 hepatic adenoma, somatic 12.0
21 adrenal cortical adenoma 12.0
22 nephrogenic adenoma 12.0
23 metanephric adenoma 12.0
24 clear cell adenoma 11.9
25 pleomorphic adenoma carcinoma 11.9
26 eccrine papillary adenoma 11.9
27 follicular adenoma 11.9
28 pituitary adenoma, growth hormone-secreting 2 11.9
29 papillary adenoma 11.8
30 chromophobe adenoma 11.8
31 adenomas, multiple colorectal 11.8
32 microcystic adenoma 11.8
33 lung adenoma 11.8
34 functioning pituitary adenoma 11.8
35 middle ear adenoma 11.8
36 intrahepatic bile duct adenoma 11.8
37 oxyphilic adenoma 11.8
38 acidophil adenoma 11.8
39 renal adenoma 11.8
40 basophil adenoma 11.8
41 apocrine adenoma 11.8
42 aip-related familial isolated pituitary adenomas 11.8
43 gallbladder adenoma 11.8
44 gastrointestinal adenoma 11.8
45 fetal adenoma 11.8
46 chief cell adenoma 11.7
47 colon adenoma 11.7
48 periampullary adenoma 11.7
49 breast adenoma 11.7
50 adenoma of pancreas 11.7

Graphical network of the top 20 diseases related to Adenoma:



Diseases related to Adenoma

Symptoms & Phenotypes for Adenoma

GenomeRNAi Phenotypes related to Adenoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-101 9.94 HSD11B2
2 Increased shRNA abundance (Z-score > 2) GR00366-A-108 9.94 THADA
3 Increased shRNA abundance (Z-score > 2) GR00366-A-11 9.94 KRAS
4 Increased shRNA abundance (Z-score > 2) GR00366-A-115 9.94 SLC26A3
5 Increased shRNA abundance (Z-score > 2) GR00366-A-12 9.94 TP53
6 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.94 TP53 KRAS SLC26A3 THADA HSD11B2
7 Increased shRNA abundance (Z-score > 2) GR00366-A-122 9.94 THADA
8 Increased shRNA abundance (Z-score > 2) GR00366-A-128 9.94 SLC26A3
9 Increased shRNA abundance (Z-score > 2) GR00366-A-132 9.94 TP53
10 Increased shRNA abundance (Z-score > 2) GR00366-A-135 9.94 SLC26A3
11 Increased shRNA abundance (Z-score > 2) GR00366-A-147 9.94 THADA HSD11B2
12 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.94 HSD11B2
13 Increased shRNA abundance (Z-score > 2) GR00366-A-168 9.94 KRAS
14 Increased shRNA abundance (Z-score > 2) GR00366-A-169 9.94 TP53
15 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.94 KRAS
16 Increased shRNA abundance (Z-score > 2) GR00366-A-19 9.94 TP53
17 Increased shRNA abundance (Z-score > 2) GR00366-A-190 9.94 TP53
18 Increased shRNA abundance (Z-score > 2) GR00366-A-194 9.94 THADA
19 Increased shRNA abundance (Z-score > 2) GR00366-A-196 9.94 KRAS
20 Increased shRNA abundance (Z-score > 2) GR00366-A-22 9.94 KRAS
21 Increased shRNA abundance (Z-score > 2) GR00366-A-23 9.94 KRAS
22 Increased shRNA abundance (Z-score > 2) GR00366-A-35 9.94 TP53
23 Increased shRNA abundance (Z-score > 2) GR00366-A-39 9.94 TP53
24 Increased shRNA abundance (Z-score > 2) GR00366-A-4 9.94 THADA
25 Increased shRNA abundance (Z-score > 2) GR00366-A-49 9.94 KRAS
26 Increased shRNA abundance (Z-score > 2) GR00366-A-50 9.94 KRAS HSD11B2
27 Increased shRNA abundance (Z-score > 2) GR00366-A-51 9.94 HSD11B2
28 Increased shRNA abundance (Z-score > 2) GR00366-A-54 9.94 SLC26A3
29 Increased shRNA abundance (Z-score > 2) GR00366-A-57 9.94 HSD11B2
30 Increased shRNA abundance (Z-score > 2) GR00366-A-63 9.94 HSD11B2 KRAS
31 Increased shRNA abundance (Z-score > 2) GR00366-A-73 9.94 HSD11B2
32 Increased shRNA abundance (Z-score > 2) GR00366-A-81 9.94 SLC26A3
33 Increased shRNA abundance (Z-score > 2) GR00366-A-83 9.94 THADA
34 Increased shRNA abundance (Z-score > 2) GR00366-A-93 9.94 KRAS
35 Decreased viability in esophageal squamous lineage GR00235-A 9.73 CCND1 CTNNB1 GNAS KRAS MEN1 MLH1

MGI Mouse Phenotypes related to Adenoma:

44 (show all 19)
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.41 CCND1 CTNNB1 GNAS HSD11B2 KRAS LHCGR
2 homeostasis/metabolism MP:0005376 10.41 TGFBR2 TP53 CCND1 CTNNB1 GNAS HSD11B2
3 growth/size/body region MP:0005378 10.37 TGFBR2 TP53 CCND1 CTNNB1 GNAS KRAS
4 behavior/neurological MP:0005386 10.36 TP53 CCND1 CTNNB1 GNAS HSD11B2 KRAS
5 endocrine/exocrine gland MP:0005379 10.35 CCND1 CTNNB1 GNAS KRAS LHCGR MEN1
6 digestive/alimentary MP:0005381 10.33 TGFBR2 TP53 CCND1 CTNNB1 HSD11B2 KRAS
7 mortality/aging MP:0010768 10.31 CCND1 CTNNB1 GNAS HSD11B2 KRAS MEN1
8 cardiovascular system MP:0005385 10.27 CCND1 CTNNB1 GNAS HSD11B2 KRAS MEN1
9 immune system MP:0005387 10.24 MEN1 POMC PRL SST TGFBR2 TP53
10 neoplasm MP:0002006 10.18 CCND1 CTNNB1 GNAS HSD11B2 KRAS MEN1
11 nervous system MP:0003631 10.15 MEN1 MUTYH PLAGL1 POMC PRL SST
12 integument MP:0010771 10.13 PRL TP53 CCND1 CTNNB1 GNAS KRAS
13 craniofacial MP:0005382 10.1 CCND1 CTNNB1 GNAS KRAS MEN1 TGFBR2
14 liver/biliary system MP:0005370 10.06 CTNNB1 GNAS KRAS MEN1 POMC PRL
15 no phenotypic analysis MP:0003012 9.92 CTNNB1 GNAS HSD11B2 KRAS PLAGL1 POMC
16 reproductive system MP:0005389 9.81 CCND1 CTNNB1 KRAS LHCGR MEN1 MLH1
17 renal/urinary system MP:0005367 9.8 CTNNB1 GNAS HSD11B2 KRAS LHCGR POMC
18 respiratory system MP:0005388 9.56 CCND1 CTNNB1 GNAS KRAS MLH1 PLAGL1
19 skeleton MP:0005390 9.28 CCND1 CTNNB1 GNAS KRAS LHCGR PLAGL1

Drugs & Therapeutics for Adenoma

Drugs for Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 541)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-61-6, 62-31-7 681
2
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
3
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
4
Erythromycin Approved, Vet_approved Phase 4 114-07-8 12560
5
Pantoprazole Approved Phase 4 102625-70-7 4679
6
Metformin Approved Phase 4,Phase 2,Phase 1 657-24-9 14219 4091
7
Octreotide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 83150-76-9 383414 6400441
8
Ticlopidine Approved Phase 4 55142-85-3 5472
9
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-23-7 5754 657311
10
Cabergoline Approved Phase 4,Phase 2,Phase 3 81409-90-7 54746
11
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 1 22916-47-8 4189
12
Everolimus Approved Phase 4,Phase 2,Phase 1 159351-69-6 6442177
13
Ecabet Approved, Investigational Phase 4 33159-27-2, 86408-72-2 65781
14
Sunitinib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 341031-54-7, 557795-19-4 5329102
15
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2 2216-51-5 16666
16
Sirolimus Approved, Investigational Phase 4,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
17
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
18
Magnesium oxide Approved Phase 4 1309-48-4 14792
19
Celecoxib Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 169590-42-5 2662
20
lanreotide Approved Phase 4,Phase 3,Phase 2 108736-35-2
21
Somatostatin Approved Phase 4,Phase 2,Phase 3,Phase 1 38916-34-6, 51110-01-1 53481605
22
Zinc Approved Phase 4,Phase 3 7440-66-6 32051 23994
23
Clarithromycin Approved Phase 4 81103-11-9 84029
24
Sulfamethoxazole Approved Phase 4 723-46-6 5329
25
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
26
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
27
Liraglutide Approved Phase 4 204656-20-2
28
Cefazolin Approved Phase 4 25953-19-9 656510 33255
29
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
30
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
31
Cefdinir Approved Phase 4 91832-40-5 6915944
32
leucovorin Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1 58-05-9 54575, 6560146 143
33
Vitamin C Approved, Nutraceutical Phase 4,Phase 3,Phase 2 50-81-7 5785 54670067
34
Clopidogrel Approved, Nutraceutical Phase 4 120202-66-6, 113665-84-2 60606
35
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 59-30-3 6037
36
Butyric Acid Experimental Phase 4 107-92-6 264
37 glucagon Phase 4,Phase 1,Early Phase 1
38 pancreatic polypeptide Phase 4,Phase 2,Phase 3,Phase 1
39 Scopolamine hydrobromide Phase 4 114-49-8
40
Proton pump inhibitors Phase 4
41 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
42 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
43 Dopamine agonists Phase 4,Phase 2,Phase 3,Phase 1
44
protease inhibitors Phase 4,Phase 3,Phase 2,Phase 1
45 Chelating Agents Phase 4,Phase 3,Phase 2,Phase 1
46 Muscarinic Antagonists Phase 4
47 Cholinergic Agents Phase 4
48 Adjuvants, Anesthesia Phase 4,Phase 3,Phase 1
49 Mydriatics Phase 4,Phase 3,Phase 2
50 Folic Acid Antagonists Phase 4,Phase 2,Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 1055)
id Name Status NCT ID Phase
1 Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate? Unknown status NCT01609855 Phase 4
2 Efficacy Combined Fecal Immunochemical Test-Sigmoidoscopy for the Detection of Advanced Colorectal Neoplasia Unknown status NCT01767870 Phase 4
3 Prophylactic Pancreatic Duct Stent Placement After ESP of Major Papillary Tumors; Prospective, Randomized Study Unknown status NCT01737463 Phase 4
4 Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis Unknown status NCT02175914 Phase 4
5 Participation and Detection Rate Diagnostic of a Colorectal Cancer Screening Program: CT Colonography vs. Flexible Sigmoidoscopy Unknown status NCT01739608 Phase 4
6 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4
7 Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection Unknown status NCT01308177 Phase 4
8 Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies Unknown status NCT01481714 Phase 4
9 Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism Unknown status NCT02127840 Phase 4
10 Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions Unknown status NCT02190994 Phase 4
11 Characterization of Receptors in Non-functioning Pituitary Macroadenomas Unknown status NCT00852501 Phase 4
12 Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors Unknown status NCT00454376 Phase 4
13 Endoscopy Nurse Participation in Adenoma Detection Rate During Colonoscopy Completed NCT01124266 Phase 4
14 Surgical Debulking of Pituitary Adenomas Completed NCT01371643 Phase 4
15 Effect of Gum Chewing on Bowel Cleansing Before Colonoscopy Completed NCT02507037 Phase 4
16 Preoperative Octreotide Treatment of Acromegaly Completed NCT00521300 Phase 4
17 A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate) Completed NCT01689792 Phase 4
18 Octreotide Efficacy and Safety in First-line Acromegalic Patients Completed NCT00171886 Phase 4
19 Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) Completed NCT01494337 Phase 4
20 BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia Completed NCT01533038 Phase 4
21 Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment Completed NCT03080181 Phase 4
22 Evaluation of the Effects of Different Prostate Surgeries on Urinary and Sexual Function Completed NCT01810068 Phase 4
23 A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. Completed NCT01861717 Phase 4
24 Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly Completed NCT00376064 Phase 4
25 Cardiac Valve Complications in Prolactinomas Treated With Cabergoline Completed NCT00460616 Phase 4
26 Comparative Study of Postprocessing Imaging Systems for Diminutive Colonic Polyps Completed NCT01133041 Phase 4
27 Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding Recruiting NCT02032784 Phase 4
28 Transanal Endoscopic Microsurgery Versus Endoscopic Submucosal Dissection For Large Rectal Adenomas Recruiting NCT01023984 Phase 4
29 Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Recruiting NCT02638584 Phase 4
30 Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions Recruiting NCT03014687 Phase 4
31 Glucagon and Colonoscopy Recruiting NCT02078726 Phase 4
32 HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH Recruiting NCT02737241 Phase 4
33 Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly Recruiting NCT02115906 Phase 4
34 Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China Recruiting NCT02842749 Phase 4
35 Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Recruiting NCT02060383 Phase 4
36 Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Recruiting NCT01794793 Phase 4
37 Oral Sulfate Solution (SUPREP) Versus Polyethylene Glycol (PEG) Plus Ascorbic Acid Recruiting NCT02761213 Phase 4
38 Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp Recruiting NCT03065868 Phase 4
39 GreenLight Laser Photoselective Vaporization of the Prostate vs Plasma Kinetic Vaporization of the Prostate; RCT Active, not recruiting NCT02283684 Phase 4
40 A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors Active, not recruiting NCT01525550 Phase 4
41 Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors Active, not recruiting NCT02759718 Phase 4
42 Impact of Reinforced Education by Wechat and Short Message Service on the Quality of Bowel Preparation Not yet recruiting NCT02832869 Phase 4
43 Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version Not yet recruiting NCT02354560 Phase 4
44 A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) Terminated NCT00140894 Phase 4
45 Single Arm Post-marketing Study of SC20 Colonoscope Terminated NCT02279836 Phase 4
46 Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients Terminated NCT00151476 Phase 4
47 Effectiveness of Instillation of Blue Water (Indigo Carmin®) for Colonoscopy Unknown status NCT01937429 Phase 3
48 Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients Unknown status NCT00134758 Phase 2, Phase 3
49 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Unknown status NCT01157598 Phase 3
50 NORCCAP: Norwegian Colorectal Cancer Prevention Trial Unknown status NCT00119912 Phase 2, Phase 3

Search NIH Clinical Center for Adenoma

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Adenoma

Anatomical Context for Adenoma

MalaCards organs/tissues related to Adenoma:

39
Pituitary, Thyroid, Colon, Salivary Gland, Prostate, Lung, Pancreas

Publications for Adenoma

Articles related to Adenoma:

(show top 50) (show all 7214)
id Title Authors Year
1
Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1. ( 28079577 )
2017
2
Diffusion-weighted MRI for differentiation between sialadenitis and pleomorphic adenoma. ( 27845594 )
2017
3
Adenoma Detection Rates for Screening Colonoscopies in Smokers and Obese Adults: Data From the New Hampshire Colonoscopy Registry. ( 28059941 )
2017
4
Complex effects of apoplexy secondary to pituitary adenoma. ( 27802176 )
2017
5
Central hypogonadism due to a giant, "silent" FSH-secreting, atypical pituitary adenoma: effects of adenoma dissection and short-term Leydig cell stimulation by luteinizing hormone (LH) and human chorionic gonadotropin (hCG). ( 28067604 )
2017
6
Cushing's syndrome managed by endoscopic ultrasound-guided radiofrequency ablation of adrenal gland adenoma. ( 28068682 )
2017
7
Pituitary Adenoma and Hyperprolactinemia Accompanied by Idiopathic Granulomatous Mastitis. ( 28321344 )
2017
8
Hemifacial Spasm Secondary to Parotid Pleomorphic Adenoma With Stylomastoid Foramen Extension. ( 27755360 )
2017
9
Mixed Gangliocytoma-Pituitary Adenoma: Insights on the Pathogenesis of a Rare Sellar Tumor. ( 28079576 )
2017
10
Pituitary adenoma with adipose tissue: A new metaplastic variant. ( 28070930 )
2017
11
Cap cuff-assisted colonoscopy versus standard colonoscopy for adenoma detection: a randomized back-to-back study. ( 28082115 )
2017
12
Association between dietary fat intake and colorectal adenoma in korean adults: A cross-sectional study. ( 28072719 )
2017
13
An intrasellar pituitary adenoma-gangliocytoma presenting as acromegaly. ( 28469929 )
2017
14
mTUEPA: Trans-Urethral Monopolar Enucleation of Prostatic Adenoma. Preliminary Report. ( 28087281 )
2017
15
Giant parathyroid adenoma: differential aspects compared to parathyroid carcinoma. ( 28491324 )
2017
16
A Case of Coincidental Intrasellar Chordoma and Pituitary Adenoma. ( 28516081 )
2017
17
Simultaneous Occurrence of a Pituitary Adenoma and a Foramen Magnum Meningioma: Case Report. ( 27989978 )
2017
18
Decreased TAp63 and I9Np63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression. ( 28078618 )
2017
19
The association between location, age and advanced colorectal adenoma characteristics: a propensity-matched analysis. ( 27686516 )
2017
20
Villous Adenoma in Renal Pelvis with Manifestation of Percutaneous Fistula and Mucus Secretion. ( 28069333 )
2017
21
Vitamin D and Calcium for Colorectal Adenoma Chemoprevention. ( 27929663 )
2017
22
Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations. ( 27681703 )
2017
23
Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development? ( 28194042 )
2017
24
Relationship between RSUME and HIF-1I+/VEGF-A with invasion of pituitary adenoma. ( 27989771 )
2017
25
Spinal adrenal cortical adenoma associated with Beckwith-Wiedemann syndrome: case report and review of the literature. ( 28365908 )
2017
26
Protean Presentations of Parathyroid Adenoma in Childhood. ( 28082776 )
2017
27
Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/I^-catenin signaling pathway in human colorectal adenocarcinoma. ( 28259923 )
2017
28
BRUNNER GLAND ADENOMA MASQUERADING AS DUODENAL GASTROINTESTINAL STROMAL TUMOR WITH INTUSSUSCEPTION: CASE REPORT. ( 28489176 )
2017
29
Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma. ( 28072871 )
2017
30
Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma. ( 27227698 )
2017
31
Dermoscopy of adenoma sebaceum. ( 28087045 )
2017
32
Malignant transformation of a I^-catenin inflammatory adenoma due to an S45 I^-catenin-activating mutation present 12 years before. ( 27984126 )
2017
33
Increased I^a89catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach. ( 28260015 )
2017
34
Submucosal injection with waterjet improves endoscopic mucosal resection of colorectal adenoma - a randomised controlled clinical trial. ( 27797282 )
2017
35
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report. ( 28061802 )
2017
36
Synchronous contralateral pleomorphic adenoma of the parotid gland and submandibular gland. ( 27914682 )
2017
37
SY 03-3 OVERVIEW OF SOMATIC MUTATIONS AND EPIGENETIC REGULATION OF ALDOSTERONE PRODUCING ADENOMA (APA). ( 27642883 )
2016
38
Encapsulated relapsed flt3+AML (myeloid sarcoma) and hurthle cell adenoma presenting in composite: unlikely partners. ( 27643393 )
2016
39
A case report of mediastinal ectopic parathyroid adenoma presented as parathyroid crisis localized by SPECT/CT. ( 27741147 )
2016
40
Hepatocellular adenoma: when and how to treat? Update of current evidence. ( 27803743 )
2016
41
Metanephric adenoma: Cytological, histological, and molecular diagnosis of a case. ( 26800350 )
2016
42
GNAS mutations in adrenal aldosterone-producing adenomas. ( 26743443 )
2016
43
Diagnosis of a rapidly growing preauricular nodule: chondroid syringoma or pleomorphic adenoma? ( 27874890 )
2016
44
Genomic profile of a squamous cell carcinoma ex pleomorphic adenoma compared to a head and neck squamous cell carcinoma. ( 26971044 )
2016
45
Loss Expression of Plag1 in Malignant Transformation from Pleomorphic Adenoma to Carcinoma Ex-Pleomorphic Adenoma. ( 27473265 )
2016
46
Video Assisted Thoracoscopic Surgery (VATS) for Excision of an Ectopic Anterior Mediastinal Intra-Thymic Parathyroid Adenoma. ( 27504353 )
2016
47
Carcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland with Epithelial-Myoepithelial Carcinoma Histologic Type. ( 26934566 )
2016
48
The role of OsiriX based virtual endoscopy in planning endoscopic transsphenoidal surgery for pituitary adenoma. ( 27593805 )
2016
49
Pleomorphic adenoma in the nasal cavity: a clinicopathological study of ten cases in Finland. ( 27056196 )
2016
50
The role of FSCN1 in migration and invasion of pituitary adenomas. ( 26522130 )
2016

Variations for Adenoma

Expression for Adenoma

Search GEO for disease gene expression data for Adenoma.

Pathways for Adenoma

Pathways related to Adenoma according to GeneCards Suite gene sharing:

(show all 21)
id Super pathways Score Top Affiliating Genes
1 12.49 CCND1 GH1 KRAS PRL TP53
2
Show member pathways
12.44 CCND1 CTNNB1 KRAS TGFBR2 TP53
3
Show member pathways
12.36 CCND1 GH1 KRAS LHCGR PRL
4 12.3 CCND1 CTNNB1 GNAS KRAS MLH1 TGFBR2
5 12.21 CCND1 CTNNB1 KRAS TGFBR2 TP53
6 12.18 CCND1 CTNNB1 KRAS TP53
7
Show member pathways
12.12 CTNNB1 GNAS KRAS POMC TP53
8
Show member pathways
12.09 CCND1 CTNNB1 KRAS MLH1 TGFBR2 TP53
9
Show member pathways
11.98 CCND1 KRAS TGFBR2 TP53
10 11.96 CCND1 KRAS MLH1 TP53
11 11.91 CCND1 CTNNB1 KRAS TGFBR2 TP53
12 11.86 CCND1 CTNNB1 KRAS TP53
13 11.84 CCND1 CTNNB1 KRAS TP53
14 11.78 CCND1 CTNNB1 KRAS TP53
15 11.67 POMC PRL TP53
16 11.62 CCND1 KRAS TP53
17 11.38 CCND1 CTNNB1 GNAS KRAS MLH1 TGFBR2
18 11.11 CTNNB1 KRAS TGFBR2
19 10.72 CCND1 CTNNB1 KRAS TP53
20 10.71 CTNNB1 SST
21 10.71 CTNNB1 MEN1

GO Terms for Adenoma

Biological processes related to Adenoma according to GeneCards Suite gene sharing:

(show all 15)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription from RNA polymerase II promoter GO:0045944 9.98 CTNNB1 MEN1 PLAG1 PLAGL1 PLAGL2 POMC
2 positive regulation of cell proliferation GO:0008284 9.95 CCND1 CTNNB1 KRAS PRL TGFBR2
3 cellular response to DNA damage stimulus GO:0006974 9.89 CCND1 MEN1 MLH1 MUTYH TP53
4 negative regulation of cell proliferation GO:0008285 9.85 CTNNB1 MEN1 SST TGFBR2 TP53
5 response to nutrient GO:0007584 9.71 PRL SST TGFBR2
6 response to glucocorticoid GO:0051384 9.65 CCND1 HSD11B2 KRAS
7 response to estradiol GO:0032355 9.56 CCND1 CTNNB1 GH1 PRL
8 mitotic G1 DNA damage checkpoint GO:0031571 9.52 CCND1 TP53
9 positive regulation of cAMP-mediated signaling GO:0043950 9.51 GNAS LHCGR
10 female pregnancy GO:0007565 9.46 GNAS HSD11B2 KRAS PRL
11 hair follicle placode formation GO:0060789 9.4 CTNNB1 GNAS
12 trachea formation GO:0060440 9.37 CTNNB1 TGFBR2
13 trachea morphogenesis GO:0060439 9.32 CTNNB1 TGFBR2
14 response to steroid hormone GO:0048545 9.26 CCND1 HSD11B2 SST TGFBR2
15 response to drug GO:0042493 9.17 CCND1 CTNNB1 GNAS HSD11B2 PRL SST

Molecular functions related to Adenoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.26 GH1 POMC PRL SST
2 MutSalpha complex binding GO:0032407 9.16 MLH1 MUTYH
3 prolactin receptor binding GO:0005148 8.62 GH1 PRL

Sources for Adenoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....